Trending Vaping Studies Conducted in 2019
As the vaping debate continues to heat up, more studies are being performed to determine the long-term effects of vaping compared to those associated with cigarette consumption. Most are aware how the FDA is getting closer to coming up with a clear list of guidelines and regulations regarding the ways in which the vaping industry can be marketed and sold. Therefore, we’re seeing an increase in funding going toward studies that examine how vaping affects the human body, the makeup of its second-hand emissions and potential effectiveness for those looking to make the switch.
Below are two vaping studies that have been performed this year. Each supports the notion that vaping should be made as accessible as possible to the public, especially for those looking for a way to quit smoking.
Vape Study #1: Smoking is Down in the United Kingdom Largely Thanks to Vaping
Public Health England has yet again proven that the United Kingdom is far more friendly toward vaping than the United States thanks to a study performed this July. The research found that cigarette use continues to decrease throughout the UK while vaping is becoming more and more popular than ever before. This data strongly suggests that vaping can be a highly successful smoking cessation tool for those who are trying to get off of cigarettes for good.
The government believes that vaping is a far better alternative to smoking in terms of its effects on a person’s health. The fact that so many UK citizens have managed to quit smoking in favor of vaping is the result of how accessible the United Kingdom has made this technology.
Vape Study #2: Smoking Can Damage the Neuroimmune SystemA recent June study showed that cigarette use can damage the body’s neuroimmune system, which is the system that connects the immune and the nervous systems. It explains why those with a compromised immune system may experience cognitive decline. According to the study, certain toxins found in cigarette smoke can impair the immune system’s ability to fight off infections while decreasing cognitive function.
The study examined the neuroimmune systems of 16 smokers and 19 people who don’t smoke. Then, the participants were injected with inflammatory stimulus lipopolysaccharide. The group of smokers had lower responses to the injection than those who don’t smoke. This data suggests that smokers are at a high risk of both cognitive dysfunction and immune dysfunction.
As the year continues, more research needs to be conducted in order to further demonstrate to the public that vaping should be recognized as a smoking cessation tool. For now, however, researchers still have many studies in the works for the remainder of the year.